Publications (co-)authored by Jeff Kuret with students in the Biophysics program

[1] 

Carol J Huseby, Ralf Bundschuh, and Jeff Kuret
"The role of annealing and fragmentation in human tau aggregation dynamics."
J. Biol. Chem. 294, 4728-4737 (2019).

[2] 

Carol J Huseby, Claire N Hoffman, Grace L Cooper, Jean-Christophe Cocuron, Ana P Alonso, Stefani N Thomas, Austin J Yang, and Jeff Kuret
"Quantification of Tau Protein Lysine Methylation in Aging and Alzheimers Disease."
J. Alzheimers Dis. 71, 979-991 (2019).

[3] 

Grace L Cooper, Carol J Huseby, Claire N Chandler, Jean-Christophe Cocuron, Ana P Alonso, and Jeff Kuret
"A liquid chromatography tandem mass spectroscopy approach for quantification of protein methylation stoichiometry."
Anal. Biochem. 545, 72-77 (2018).

[4] 

Carol J Huseby and Jeff Kuret
"Analyzing Tau Aggregation with Electron Microscopy."
Methods Mol. Biol. 1345, 101-12 (2016).

[5] 

Kristen E Funk, Stefani N Thomas, Kelsey N Schafer, Grace L Cooper, Zhongping Liao, David J Clark, Austin J Yang, and Jeff Kuret
"Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity."
Biochem. J. 462, 77-88 (2014).

[6] 

Katryna Cisek, Grace L Cooper, Carol J Huseby, and Jeff Kuret
"Structure and mechanism of action of tau aggregation inhibitors."
Curr Alzheimer Res 11, 918-27 (2014).

[7] 

Kelsey N Schafer, Katryna Cisek, Carol J Huseby, Edward Chang, and Jeff Kuret
"Structural determinants of tau aggregation inhibitor potency."
J. Biol. Chem. 288, 32599-611 (2013).

[8] 

Kelsey N Schafer, Sohee Kim, Anastasios Matzavinos, and Jeff Kuret
"Selectivity requirements for diagnostic imaging of neurofibrillary lesions in Alzheimers disease: a simulation study."
Neuroimage 60, 1724-33 (2012).

[9] 

Katryna Cisek and Jeff Kuret
"QSAR studies for prediction of cross-β sheet aggregate binding affinity and selectivity."
Bioorg. Med. Chem. 20, 1434-41 (2012).

[10] 

Katryna Cisek, Jordan R Jensen, Nicolette S Honson, Kelsey N Schafer, Grace L Cooper, and Jeff Kuret
"Ligand electronic properties modulate tau filament binding site density."
Biophys. Chem. 170, 25-33 (2012).

[11] 

Jordan R Jensen, Katryna Cisek, Nicolette S Honson, and Jeff Kuret
"Ligand polarizability contributes to tau fibril binding affinity."
Bioorg. Med. Chem. 19, 5147-54 (2011).

[12] 

Kelsey N Schafer, Dhiraj P Murale, Kibong Kim, Katryna Cisek, Jeff Kuret, and David G Churchill
"Structure-activity relationship of cyclic thiacarbocyanine tau aggregation inhibitors."
Bioorg. Med. Chem. Lett. 21, 3273-6 (2011).

[13] 

Edward Chang, Sohee Kim, Kelsey N Schafer, and Jeff Kuret
"Pseudophosphorylation of tau protein directly modulates its aggregation kinetics."
Biochim. Biophys. Acta 1814, 388-95 (2011).

[14] 

Jordan R Jensen, Katryna Cisek, Kristen E Funk, Swati Naphade, Kelsey N Schafer, and Jeff Kuret
"Research towards tau imaging."
J. Alzheimers Dis. 26, 147-57 (2011).

[15] 

S Kim, J R Jensen, K Cisek, K E Funk, S Naphade, K Schafer, and J Kuret
"Imaging as a strategy for premortem diagnosis and staging of tauopathies."
Curr Alzheimer Res 7, 230-4 (2010).

[16] 

Theresa J Kannanayakal, Jerry R Mendell, and Jeff Kuret
"Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis."
Neurosci. Lett. 431, 141-5 (2008).

[17] 

Erin E Congdon, Mihaela Necula, Robert D Blackstone, and Jeff Kuret
"Potency of a tau fibrillization inhibitor is influenced by its aggregation state."
Arch. Biochem. Biophys. 465, 127-35 (2007).

[18] 

Theresa J Kannanayakal, Haiyang Tao, Dale D Vandre, and Jeff Kuret
"Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions."
Acta Neuropathol. 111, 413-21 (2006).

[19] 

Mihaela Necula, Carmen N Chirita, and Jeff Kuret
"Cyanine dye N744 inhibits tau fibrillization by blocking filament extension implications for the treatment of tauopathic neurodegenerative diseases."
Biochemistry 44, 10227-37 (2005).

[20] 

Jeff Kuret, Erin E Congdon, Guibin Li, Haishan Yin, Xian Yu, and Qi Zhong
"Evaluating triggers and enhancers of tau fibrillization."
Microsc. Res. Tech. 67, 141-55 (2005).

[21] 

Carmen N Chirita, Erin E Congdon, Haishan Yin, and Jeff Kuret
"Triggers of full-length tau aggregation a role for partially folded intermediates."
Biochemistry 44, 5862-72 (2005).

[22] 

Mihaela Necula and Jeff Kuret
"Site-specific pseudophosphorylation modulates the rate of tau filament dissociation."
FEBS Lett. 579, 1453-7 (2005).

[23] 

Jeff Kuret, Carmen N Chirita, Erin E Congdon, Theresa Kannanayakal, Guibin Li, Mihaela Necula, Haishan Yin, and Qi Zhong
"Pathways of tau fibrillization."
Biochim. Biophys. Acta 1739, 167-78 (2005).

[24] 

Mihaela Necula and Jeff Kuret
"Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro."
J. Biol. Chem. 279, 49694-703 (2004).

[25] 

Mihaela Necula and Jeff Kuret
"A static laser light scattering assay for surfactant-induced tau fibrillization."
Anal. Biochem. 333, 205-15 (2004).

[26] 

Mihaela Necula and Jeff Kuret
"Electron microscopy as a quantitative method for investigating tau fibrillization."
Anal. Biochem. 329, 238-46 (2004).

[27] 

Carmen Chirita, Mihaela Necula, and Jeff Kuret
"Ligand-dependent inhibition and reversal of tau filament formation."
Biochemistry 43, 2879-87 (2004).

[28] 

Carmen N Chirita and Jeff Kuret
"Evidence for an intermediate in tau filament formation."
Biochemistry 43, 1704-14 (2004).

[29] 

Mihaela Necula, Carmen N Chirita, and Jeff Kuret
"Rapid anionic micelle-mediated alpha-synuclein fibrillization in vitro."
J. Biol. Chem. 278, 46674-80 (2003).

[30] 

Carmen N Chirita, Mihaela Necula, and Jeff Kuret
"Anionic micelles and vesicles induce tau fibrillization in vitro."
J. Biol. Chem. 278, 25644-50 (2003).

© 2018, The Ohio State University Site Administrator Login